Status:

RECRUITING

Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)

Lead Sponsor:

Medical University of South Carolina

Collaborating Sponsors:

Northwestern University

National Institutes of Health (NIH)

Conditions:

Spinal Cord Injuries and Disorders (SCI/D)

Spinal Cord Injury

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this research study is to examine the effect of a brain stimulation training to improve the function of brain-spinal cord- muscle connections. Because brain-to-muscle pathways are very ...

Detailed Description

Regaining arm/hand function is one of the top priorities of individuals with tetraplegia and is a challenging problem, partly due to the complex nature of upper limb motor function. Through mass pract...

Eligibility Criteria

Inclusion

  • Adult (≥18 yrs old)
  • a history of injury to spinal cord at or above C6
  • neurologically stable (\>1 year post SCI)
  • medical clearance to participate
  • weak wrist extension at least unilaterally
  • expectation that current medication will be maintained without change for at least 3 months.
  • Stable use of anti-spasticity medication (e.g., baclofen, diazepam, tizanidine) is accepted. (Because only neurologically stable subjects will enter this study, medication changes will be unlikely.)
  • In participants with bilateral wrist extension weakness in whom Extensor Carpi Radialis (ECR) MEP can be elicited in both arms, the more severely impaired arm is studied. In participants with unilateral wrist weakness or in participants with bilateral wrist weakness in whom an ECR MEP can be elicited in only one arm, that arm is studied.

Exclusion

  • motoneuron injury
  • unstable medical condition
  • cognitive impairment (because the studied intervention is a learning-based intervention)
  • a history of epileptic seizures
  • a pre-existing or confounding neurological condition (e.g., history of MS, Stroke, Parkinson's disease)
  • metal implants in the cranium
  • implanted biomedical device in or above the chest (e.g., a cardiac pacemaker, cochlear implant)
  • no measurable MEP elicited in the ECR
  • inability to produce any voluntary ECR EMG activity
  • extensive use of functional electrical stimulation to the arm on a daily basis (as it may interfere with or augment the effects of MEP conditioning itself)
  • pregnancy (due to changes in posture and potential medical instability)
  • inability or unwillingness of subject or legal guardian/representative to give informed consent

Key Trial Info

Start Date :

November 3 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2027

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT07179822

Start Date

November 3 2025

End Date

September 30 2027

Last Update

November 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University of South Carolina

Charleston, South Carolina, United States, 29407